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Summary The radiosensitivity of human tumour cell lines and cells cultured from xenografts or biopsy
specimens was measured using the adhesive tumour cell culture system (ATCCS). For cell lines the derived
surviving fractions at 2 Gy were in good agreement with values obtained by clonogenic assay. However, the
assay tended to overestimate survival at higher radiation doses, and thus to give a false impression of
radioresistance. When cells taken from xenografts or tumour biopsies were cultured there was no evidence for
selective growth of tumour cells: fibroblast-like cells commonly grew. Immunohistochemical staining against
the intermediate filament, vimentin, supported the mesenchymal origin of the fibroblast-like cells. In cultures
of artificial mixtures of tumour cells and fibroblasts, low proportions of fibroblasts were not excluded by the
assay and consequently modified the radiation response. The majority of cultures grown from bladder
carcinoma biopsy specimens appeared fibroblast-like, although in some cases clearly distinguishable colonies of
tumour cells were also grown. In such tumour types the reliable measurement of radiosensitivity in cells taken
from biopsies will require further development of techniques that allow the selective growth of tumour cells.
An interesting correlation has been found between the radio-
responsiveness of different types of human tumour and their
in vitro radiosensitivity (Fertil & Malaise, 1981; Deacon et
al., 1984). Within a single histological type the radiosensi-
tivity of isolated cell lines also shows considerable variability
and this may partly explain the range of responses observed
after clinical radiation therapy. The goal of predictive testing
is to quantify the in vitro radiosensitivity of tumour cells in a
way that is predictive for the outcome after therapy. This
might then lead on to the selection of an altered treatment
for radio-resistant tumours.
A wide variety of assays to measure the radiosensitivity of
tumour cells have been proposed (see Peters et al., 1986, for
review) of which the adhesive tumour cell culture system
(ATCCS) developed by Baker et al. (1986) has been reported
as a major advance (Baker et al., 1985, 1988a; Brock et al.,
1985; Ajani et al., 1987; Malaise et al., 1987; Peters et al.,
1987). The growth of cells adhering to a coated or uncoated
plastic surface is a standard practice in tissue culture;
ATCCS will here refer to the method described by the Hous-
ton group.
The ATCCS has been developed and investigated by Baker
and colleagues for both radiosensitivity and chemosensitivity
testing (Baker et al., 1986; Ajani et al., 1987; Fan et al.,
1987). An improved method for growth of human tumour
cells has been claimed using a coating of cell adhesive matrix
(CAM) on the surface of multi-well plates and a comprehen-
sive range of additives in the culture medium. Cells are
released from biopsy samples by enzymatic digest. Over the
culture period the assay conditions are reported to enhance
the growth of human tumour cells.
The ATCCS is a growth assay rather than a clonogenic
assay and relies on the selective growth of tumour cells. A
wide spectrum of tumours can be cultured (e.g. head and
neck, melanoma, colorectal tumours) and a value represent-
ing radiosensitivity can be obtained for individual patients'
tumours at around 14 days after culturing.
Primary cultures of human tumour cells have been difficult
to obtain because of variable growth in vitro. This led
Courtenay and Mills (1978) to develop a soft agar cloning
assay which has been subsequently confirmed as an improve-
ment over the Hamburger and Salmon (1977) assay. In the
Courtenay and Mills assay tumour cells grow as spherical
colonies in an agar layer whilst the growth of cells that
require anchorage to a solid substrate (e.g. fibroblasts) is
inhibited. Unfortunately, clonogenic assays generally give low
plating efficiencies, often in the range of 0.1% or less
(Courtenay & Mills, 1978; West et al., 1989). Furthermore,
this assay often requires a culture period of around 4 weeks
and is therefore difficult to incorporate into treatment plann-
ing.
This paper presents our experience of using the ATCCS
since late 1988 when the CAM coated plates were made
available to us. Our experiments were designed to investigate
radiosensitivity parameters derived using the ATCCS and to
compare with a clonogenic assay. For this purpose two cer-
vix tumour lines, one bladder line and two neuroblastoma
lines were assayed. To investigate the response using cells
taken directly from solid tumours, we have used xenografts
of bladder and cervix tumours. Preliminary data will also be
presented for cultures obtained from human tumour biopsies.
Materials and methods
Culture-adapted tumour cell lines derived from biopsies of
cervix (HX156 and HX171), bladder (MGH-U1) and neuro-
blastoma (SKN-SH and HX142) were used in this study
(Kelland & Steel, 1988; Deacon et al., 1985). These cell lines
were cultured (between passage numbers 5 and 150) in either
Dulbecco's modified MEM or Ham's F-12 media containing
10% fetal calf serum and cultured in a gassing incubator
operating at 10% carbon dioxide, -1% oxygen at 37'C.
Human fetal lung fibroblasts (HFL), in early passage, were
kindly provided by Prof. J.R. Roberts at this Institute.
The ATCCS was performed according to the description of
Baker et al. (1986). Briefly, cells were seeded into 24-well
CAM-coated plates (Baker's Dozen, Houston, TX, USA) at
four different dilutions in their respective media. The addi-
tion of methyl cellulose to this attachment medium is report-
ed to aid even distribution of cells on the culture surface.
However we did not find it aided the pattern of cell attach-
ment and was therefore omitted from this study. In some
cases biopsy digests were seeded onto 24-well plates that had
been coated with 0.5 mg ml-' human fibronectin (Collabor-
ative Research, USA).
For solid tumour digests, the culture medium was alpha-
modified Eagle's MEM, porcine sera, with the addition of
EGF, P-oestradiol, transferrin, hydrocortisone, insulin, Hepes
as described by Baker et al. (1988b). After 1 day the culture
medium was renewed and the plates were irradiated with
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graded doses of 240 kVp X-rays (HVL = 2 mmCu). Each plate
was held in a specially constructed jig overlaid with absorbers
to obtain graded radiation doses among the culture wells. In
this way each plate was given five dose levels (0, 0, 2, 3, 4,
6 Gy) at each of four different numbers of cells plated.
Cultures were observed frequently during the 14 day culture
period. At the end of this period cells were removed from a
control (0 Gy) well and ethanol fixed for subsequent DNA
analysis. The remaining wells were washed, fixed and stained
with either 0.5% crystal violet or Methylene Blue. After
drying, these cultures were microscopically examined and the
morphology of the cells observed. These plates were sent to
Dr W. Brock (at the M.D. Anderson Hospital, Houston) to
measure the staining density (integrated optical density, IOD)
of each well using a Magiscanner (Joyce-Loebl, Gateshead,
UK). The relationship between IOD and cell innoculum size
was fitted by linear regression. Small corrections were applied
to the data for each plate representing the IOD for the
stained plastic surface alone and for the variation in cell
number initially seeded per well using 3H-TdR suicide (Baker
et al., 1986). Cytotoxicity was estimated from the ratio of the
slope of the regression fit for the irradiated wells to that for
the control wells. The derived radiation response was
therefore termed 'slope ratio' (SR) and individual values
fitted using a linear-quadratic least-squares regression prog-
ram.
Xenografts of human bladder carcinomas (RT112, BT14)
and a breast carcinoma (HX99) were grown subcutaneously
in nude mice. At a tumour diameter of about 8 mm the mice
were killed and the tumour dissected. Human tumour biop-
sies were collected and stored in culture media. If it was not
possible to commence enzyme digestion on the same day as
collection the samples were stored at + 4°C overnight and
the digest started the next day. Solid tumour specimens were
weighed and chopped, followed by digestion using 0.5%
collagenase (Boehringer) and 0.004% DNAase (Sigma) for
up to 6 h at 37°C. The viable cell count was made by dye
exclusion under phase contrast microscopy. A sample of the
digest was also prepared and ethanol-fixed for subsequent
DNA content measurements.
Cells obtained from the enzyme digest were also added to
Petri dishes containing glass multiwell slides (Flow). When
the cultures were almost confluent, the cell layer was fixed in
acetone and stored at 20°C until histochemistry was per-
formed. Intermediate filament staining against cytokeratin
and vimentin was conducted using an indirect immunoperox-
idase reaction using monoclonal antibodies against cytokera-
tin (Dako-CK) or vimentin (Dako-Vimen) (Pera et al., 1987)
(antibodies supplied by Dakopatts, Copenhagen).
Experiments were also performed using mixtures of fibro-
blasts and human tumour cell lines. Between 0 and 20%
human fetal lung fibroblasts were added to a range of human
tumour cell innocula to represent the level of 'contamination'
that might be present after enzyme digest of solid tumour
biopsies. These cultures were grown and stained according to
the ATCCS procedure and IOD was measured for each
mixture.
Radiation cell survival was also measured for six further
human tumour cell lines: HX156, HX171 (cervix carcino-
mas), RT1 12, MGH-U1 (bladder carcinomas), HX142, SKN-
SH (neuroblastomas) using a standard colony assay. Cervix
tumour cell lines were grown in appropriate media supple-
mented with 2 x 105 per 5 ml heavily irradiated 3T3 mouse
fibroblast cells (Kelland & Steel, 1988). Colonies of greater
than 50 cells were scored about 14 days after irradiation.
Results
Radiation response of tumour cell lines
Implicit in the use of the ATCCS is the requirement that the
staining density (IOD) at the end of the culture period is
related to cell number. Figure 1 shows the correlation
between IOD and cervix tumour cell number measured in
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Figure 1 Relationship between integrated optical density (TOD)
and cell number at the end of the culture period. 0, HX156; 0,
HX171.
duplicate wells on the day of assay. The relationship is close
to linear for each of the two cell lines, although the data for
HX156 indicate that IOD plateaued at a value of about 3,000
as the cultures became confluent.
Two examples of the use of the CAM IOD values to
calculate radiation response are shown in Figure 2. The data
were usually consistent with a linear relationship between the
number of cells plated and IOD value. Radiation response
was calculated from the ratio of the slopes of these lines. It
can be seen from these two examples that the slope ratios
show a curvilinear relationship with dose; the curve for
HX142 is steeper than for HX156. The effect calculated at
2 Gy (SR2) using linear-quadratic equation was 0.41 and 0.74
respectively.
Table I shows the correlation between the ATCCS and
clonogenic assay of radiation response for two cervix and
two neuroblastoma cell lines. The agreement is fairly good,
suggesting that the ATCCS assay can discriminate between
cell lines that differ as widely as the cervix tumours and
neuroblastomas. There was a tendency for the SR2 values to
be slightly greater than the SF2 values; this is not surprising
and it is not necessary for the scaling of these parameters to
be the same in order for the ATCCS assay to be useful. We
conclude that on the basis of these tests the ATCCS assay
performed well in evaluating the radiosensitivity of estab-
lished tumour cell lines.
Growth ofartificial mixtures of tumour cells andfibroblasts
We have attempted to mimic the cell population obtained
from a human tumour biopsy by mixing human tumour and
human fibroblast cell lines. Figure 3 shows the appearance of
such a culture, HX156 cervix carcinoma cells mixed with
15% HFL fibroblasts. Epithelial and stromal areas can
clearly be distinguished. To test whether the ATCCS shows
specificity of growth between tumour cells and fibroblasts,
mixed cultures were set up containing 0, 5, 10, 15 or 20% of
fibroblasts and the cultures grown for the specified period.
Figure 4 shows the IOD measurements for these mixed cell
cultures. The fibroblasts alone grew quickly and they reached
confluence (and IOD values in excess of 3,500) within a
culture period of 14 days from small numbers of cells seeded.
For any seeded number of tumour cells the optical density at
Table I Comparison of ATCCS and clonogenic assay
CFE(%) Radiation response
Cell line Nunc CAM SR2 SF2b
HX156 9 (1l). 14 0.79, 0.80 0.73
HX171 - (44) - 0.72, 0.85 0.62
HX142 16 16 0.31, 0.41 0.31
SKN-SH 42 14 0.36, 0.49 0.19
aValues in parenthesis represent colony forming efficiency with
heavily irradiated feeder cells. 'Typical value from clonogenic assays.ADHESIVE HUMAN CELL CULTURE SYSTEM 937
14 days increased progressively with the number of fibro-
blasts added. The magnitude of this effect was large: 5% of
fibroblasts was equivalent to increasing the seeded tumour
cell number from approximately 6,000 to 25,000.
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Figure 3 Photomicrograph of cervix tumour cell line (HXI171)
grown with an admixture of 15% HFL fibroblasts. The tumour
cells grew in tight epithelial colonies surrounded by the more
elongated fibroblasts (mag. x 192).
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HX156 Cells Figure 4 Growth of artificial mixtures of human cervix car-
cinoma (HX156) cells and HFL fibroblasts. The IOD at 14 days is plotted against the number of tumour cells plated; - ------
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Figure 5 Phase contrast photomicrograph of cells cultured from
a bladder tumour xenograft. The tumour cells (RT112) grew in
tight epithelial colonies surrounded by the more elongated mouse
fibroblasts (mag. x 192).
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Figure 2 Evaluation of the ATCCS assay in two human tumour
cell lines. The radiation response is measured from the reduction
in slope of IOD vs cell number (upper panels). For HX156
(cervix carcinoma) and HX142 (neuroblastoma) the SR2 were
0.80 and 0.41 respectively (lower panels). Dashed line shows
linear-quadratic fit to the data.
Growth on CAMplates ofcells takenfrom xenografts and
biopsies
Enzyme digests were performed on two types of breast and
two types of bladder tumour xenografts and a variety of
human tumour biopsy specimens; bladder (50), cervix (5),
head and neck (5). Most biopsy specimens yielded very few
dye-excluding (viable) cells which attached to the culture
surface. This was evident by the large amount of debris
removed at the media change at 1 day after seeding. Cell
HX142 Cells
0
0 2 Gy
3 Gy
4 Gy
6 Gy
,10%
15%
5%
0
a)
0.
0
cn
0
0
0.1
000 25 000
0.01
iF----
0
4-
a)
0
0
0.
0.0
3000-
2000-
1000
O .
1
11938 C.S. PARKINS & G.G. STEEL
RT112 Xenograft
r -3. b">s
li
0.1
0.01
1I I
0 2 4 6
X-Ray dose (Gy)
0.001
Figure 6 Evaluation by the ATCCS method of radiation res-
ponse of cells cultured from a bladder tumour xenograft. Dashed
line shows linear-quadratic fit to the data.
growth during the 14 days was very variable, ranging from
only single cells to confluent layers of fibroblast-like cells. In
general the growth from xenograft samples was best. Figure
5 shows the morphology of cells grown from a bladder
tumour xenograft (RTl 12). Two distinct morphological cell
types can be identified. The closely packed polygonal cells are
colonies of tumour cells whereas the less densely packed cells
are fibroblasts. Neither of the cell lines changed their mor-
phology when grown in the presence of the other. Similarities
can be seen between the cells in Figure 5 and the mixtures of
HX156 and HFL cell lines shown in Figure 3. The radiation
response of the RT112 xenograft cultures is shown in Figure
6 (symbols denote results from duplicate plating). The resul-
tant radiosensitivity at 2 Gy is more resistant than that found
when the tumour cell line is cultured alone (SF2 = 0.5).
Figure 7 shows the morphology of cells grown from
human tumour biopsies. Initial experiments using the enzyme
cocktail used for the Courtenay-Mills assay (collagenase,
DNAase, pronase) yielded many cultures of fibroblast-like
cells. Omitting pronase from the cocktail resulted in better
growth of the epithelial cells, although fibroblast-like cells
were still present. A wide heterogeneity in cellular mor-
phology was observed using this culture assay. Using biLopsies
of bladder and other tumour types it was common to observe
colonies of densely packed small polygonal epithelial cells
surrounded by other more diffuse fibroblastic cells. These
cultures showed much lower growth and CFE than either cell
lines or xenografts. For a small number of these cultures the
radiation response was calculated at 2 Gy (SR2 = 0.6-0.8)
although the meaning of such a value derived from a mixture
of cell types is difficult to interpret. This problem may be
overcome using a screening test to determine the karyotype
of the cultured cells before interpretation of the radiation
response. A wider report of the evaluation of CAM plates
from our group is in preparation (Price et al., 1990).
Identification ofcells growing on CAMplates
Immunocytochemical staining for intermediate filaments was
used to distinguish between cells ofepithelial or mesenchymal
origin. Epithelial cells should be antibody positive for cyto-
keratin and negative for vimentin but mesenchymal cells
should show the opposite staining pattern. Figure 8 shows
the antibody staining pattern for tumour and fibroblast cell
lines and primary cultures obtained from biopsy specimens.
The cervix tumour cell line HX156 has a highly positive
reaction for cytokeratin and negative for vimentin whereas
the reverse is true for the fibroblast line. When the xenograft
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Figure 7 Phase contrast photomicrograph of cells cultured using
the ATCCS from biopsy specimens of bladder, larynx and
nephroblastoma tumours (mag. x 160). Tumour cell colonies
grew in tight epithelial colonies surrounded by the more elon-
gated fibroblasts. a, bladder culture (case 7789); b, larynx culture
(case 3889) (mag. x 252); c, bladder culture (case 12789); d,
nephroblastoma culture (case 291189).
culture was stained using these two antibodies it was seen
that the colonies of small tightly packed cells were positive
for cytokeratin and negative for vimentin. The mouse
fibroblast-like cells were, as expected, positive for vimentin
(using anti-mouse antibody) and negative for cytokeratin.
It was not possible to apply the immunohistochemical
staining directly to the cells adherent to the CAM coated
surface due to the action of the acetone fixative on the plastic
surface. However, primary cultures were also grown on glass
multiwell slides and the colonies that grew were mainly
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Figure 8 Immunohistochemical staining against epithelial (cyto-
keratin) and mesenchymal (vimentin) intermediate filaments, a,
Cervix tumour cell line (HXI156) stained against cytokeratin. b, Human fetal lung fibroblasts stained against vimentin. c, Tumour
cells from primary culture of nephroblastoma biopsy stained
against cytokeratin. d, Fibroblast cells from primary culture of
bladder biopsy stained against vimentin.
fibroblastic, staining positive for vimentin and negative for
cytokeratin. In those cases where mixed tumour and fibro-
blast morphologies appeared on the CAM plate, similar
morphologies appeared on the glass slides. Cells of tumour
morphology were positive for cytokeratin and those of fibro-
blastic morphology, positive for vimentin. No cross-reactivity of the antibodies was detected.
DNA index measurements
Xenografts of RTl 12 were analysed according to the ATCCS
yielding both diploid and aneuploid cells as measured by
flow-cytometry (DNA index 1.5). However, no significant
increase in the proportion ofaneuploid cells was found at the
end of the 14 day ATCCS culture period.
Discussion
The ATCCS is reported to offer two major advantages over
other assays: (1) its ability to grow and quantify human
tumour cells from a wide range of biopsy material and (2)
inhibition of growth of cell types other than tumour cells. In
order to provide meaningful data this growth assay should
reflect the underlying clonogenic response of the tumour cell
population. Growth assays only yield accurate data when the
assay conditions, e.g. the initial cell inoculum, cell growth
rate, culture period and method of assessing cell number are
optimal for the cells being assessed (Price & McMillan,
1990). An overestimation of radioresistance would be
observed if the cell number is measured at a time when
growth in the control or irradiated wells is not exponential or
if the staining density is affected by doomed or dead cells.
The choice of a fixed assay time of 14 days would be
inappropriate for cells with a range of doubling times and
this effectively limits the range of surviving fraction that can
be measured. The choice of assay time also depends upon the
initial number of cells seeded. Using human tumour cell lines
we found the derived dose-response to be in close agreement
with that from a clonogenic assay although the sensitivity at
higher doses was underestimated. The relationship between
IOD and cell inoculum size may be poorly fitted using linear
regression due to confluency. Indeed this is probably the
explanation for the observed radioresistance at high doses for
the cell lines in this study, in agreement with Malaise et al.
(1989). The derived radiosensitivity parameter would be more
accurately termed the IOD slope ratio. The response at 2Gy
has therefore been termed SR2 and not SF2 within this study.
For cells of unknown growth or cloning efficiency (CFE)
misleading values of radiosensitivity may occur and it would
be difficult to estimate the potential effect of the aforemen-
tioned variables.
For our cell lines no significant increase in CFE was
observed using the CAM coating compared to growth on
tissue culture grade surfaces. However, when cells of mixed
origin, e.g. epithelial and mesenchymal were seeded, the pro-
portion of fibroblast cells attached to the CAM surface in-
creased accordingly. The fibroblast line investigated (HFL),
although untransformed, are culture adapted and it may be
argued that their growth is not representative of the fibro-
blasts obtained from primary culture. However, the frequent
observation of fibroblasts from both biopsy samples and
xenografts suggests that the assay does not inhibit their
growth and therefore the use offibroblast cell lines is justified
in evaluating the assay. Mouse fibroblasts are normally con-
sidered to be difficult to grow in culture and their appear-
ance, and positive identification using an antibody against
mouse vimentin, in cultures from xenografts indicates the
lack of success of the assay. Primary culture growth was also
observed using alternatives to CAM surface using a range of
surface coatings, e.g. collagen, fibronectin or vitronectin
(obtained from the growth media of a germ cell tumour line
isolated by Dr M. Pera at this Institute). These coatings
increased the attachment of cells compared with bare plastic
but none showed a specific affinity for tumour cells which
was not also shown for fibroblasts.
Our preliminary results ofcell growth from human tumour
biopsies have shown great heterogeneity in morphology and
growth rate. In some cases only fibroblast-like cells grew and
in others colonies ofepithelial, polygonal, tumour cells grew.
Explanations for our observations of mixed cell morphology
compared to that reported by the group at Houston are: (1)
that our culture conditions are different; (2) that the tumour940 C.S. PARKINS & G.G. STEEL
type we digest contains a high proportion of fibroblasts; or
(3) that mixed cell morphology exists in cultures from both
groups.
Technical differences between the two studies were few.
The low oxygen tension used in this study is equal to that
used in the Courtenay-Mills assay in which it was found to
promote the growth of human tumour cells. Since there is
evidence that growth in atmospheric oxygen is equally good
(Besch et al., 1986) it is not expected that this would be an
important factor. Also differences in the batch of porcine
sera are unlikely to suppress fibroblast growth in USA but
promote their growth in UK. There were no differences in
the enzyme cocktail used although it is reported that the
yield of cell types after enzymatic digest of solid tumours is
variable and dependent upon the cocktail of enzymes applied
(Siemann et al., 1987).
The second factor may be the most important difference
between the two institutes, i.e. that the majority of biopsy
samples we have attempted to culture are from early stage I
or II bladder carcinoma. The undifferentiated nature of these
tumours and the mode of biopsy (transurethral resection
using cautery wire) may explain the high incidence of fibro-
blast growth from the bladder biopsy specimens. Better
growth ofepithelial tumour cells was obtained from the small
number of head and neck and cervix tumours, although
fibroblasts were still evident. Mixed cell morphology has been
reported for cells grown from lung and breast tumours using
the ATCCS assay (Head et al., 1989). The explanation that
mixed cultures grew in both groups needs further investiga-
tion.
A recent report from Tofilon et al. (1989) investigated the
production of SCE in primary cultures obtained using the
ATCCS. A wide heterogeneity of SCE induction was observ-
ed and this was explained as indicating heterogeneity of
radiosensitivity from the primary tumour culture. Unless the
proportion of any contaminating cell type, e.g. fibroblasts,
was assessed the findings cannot exclude the alternative con-
clusion that the cultures contained a variable proportion of
diploid fibroblasts and that these were responsible for the
heterogeneity in SCE induction.
Reduction in fibroblast cell contamination in primary cul-
ture may be expected if a screening test were applied to
detect and discard non-tumour cells before they were seeded
in the ATCCS. However our attempts to separate mixtures
of tumour cell lines from added fibroblasts, using Percoll
density centrifugation, were not successful. Until there is
evidence that the radiosensitivity of tumour cells and fibro-
blasts derived from the same patient are related in some way
the validity of the calculated SR2 value from a mixed popula-
tion is uncertain. Morphological appearance alone is insuffic-
ient to determine the proportion of cell types obtained in a
primary culture. We have not observed any change in the
growth of human tumour and fibroblast cell lines on CAM
plates and therefore believe that cells with elongated cyto-
plasmic processes (that typically grow in swirls parallel to
each other) are truly fibroblasts.
To confirm this conclusion we investigated the use of
staining against intermediate filaments as a differential
marker of tumour cells and fibroblasts. Fibroblast cells ex-
press the intermediate filament vimentin and epithelial
tumour cells express cytokeratin. We have not found any
cross reaction between the antibodies and none of our epithe-
lial tumour cell lines were positive for vimentin but all were
positive for cytokeratin. This discrimination is in contrast to
the report by Sommers et al. (1989), who reported vimentin
rather than cytokeratin expression in a small proportion of
hormone independent and oncogene-transformed cell lines.
Since the plastic plate supporting the CAM surface is not
impervious to the fixative necessary for intermediate filament
staining we have not been able to perform the definitive test
of staining against intermediate filaments directly on primary
cultures grown on CAM plates. However, the human
tumour, fibroblast and xenograft cells grown showed un-
changed staining patterns when grown on glass surfaces.
Glass microscope cover slips coated with CAM are currently
being evaluated at the M.D. Anderson Hospital, Houston to
address this question. Our attempts to transfer the CAM
from the supplied plates and re-coat glass cover slips were
not successful.
In conclusion we have found that: (1) the radiosensitivity
(SR2) of human tumour cell lines is in close agreement with
their response using a clonogenic assay; (2) the ATCCS was
unable to selectively grow human tumour cell lines when the
fibroblast contamination was 5% or greater; (3) measurement
of cell number using staining density is misleading if con-
fluency is reached or if both tumour cells and fibroblasts are
grown; (4) a high incidence of fibroblasts was observed when
human tumour xenografts were assayed; and (5) both tumour
and fibroblast cells were grown from human tumour biopsies.
Our success in growing tumour cells from human tumour
biopsies is much poorer than that reported by Houston. We
feel that this cannot totally be explained by the slight differ-
ences in culture conditions or in the tumour types chosen in
our preliminary study.
This work was funded by NCI grant no. RolCA26059. The assist-
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